Anand Mehra Aclaris Therapeutics, Inc. (ACRS) insider trading activity

ACRS Quotes by TradingView

Anand Mehra is of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 710,030 shares of ACRS, which is worth approximately $2.07 Million. The most recent transaction as insider was on Nov 19, 2024, when has been sold 666,666 shares (Common Stock) at a price of $2.25 per share, resulting in proceeds of $1,499,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 710K
1537.37% 3M change
1734.51% 12M change
Total Value Held $2.07 Million

Anand Mehra Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2024
BUY
Open market or private purchase
$1,499,998 $2.25 p/Share
666,666 Added 48.43%
710,030 Common Stock
Jun 01 2024
BUY
Exercise of conversion of derivative security
-
4,660 Added 9.7%
43,364 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
-
4,507 Added 10.43%
38,704 Common Stock
Jun 03 2022
BUY
Exercise of conversion of derivative security
-
3,356 Added 8.94%
34,197 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$268,351 $18.34 p/Share
14,632 Added 32.18%
30,841 Common Stock

Also insider at

MRUS
Merus N.V. Healthcare
AM

Anand Mehra

Utretcht, P7

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS